Physician profile
Eric Ryan Avent
NPI 1477178978
$2,164.57
in general payments reported to CMS, 2019-2025
13 companies · $376 in 2025
The $376 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $654 · 2022: $420 · 2023: $714 · 2025: $376.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,042 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,041.76 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $633.52 | 2021-2023 | Ingrezza |
| Axsome Therapeutics, INC. | $307.24 | 2023-2025 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $302.46 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $235.60 | 2021-2025 | Rexulti, Abilify Maintena |
| Abbvie INC. | $227.03 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $118.11 | 2021-2022 | |
| Alkermes, INC. | $91.44 | 2022-2023 | Lybalvi |
| Janssen Pharmaceuticals, INC | $84.54 | 2022-2023 | Spravato |
| Lundbeck LLC | $72.82 | 2021-2023 | Brintellix |
| Takeda Pharmaceuticals U.S.A., INC. | $34.74 | 2021 | |
| Indivior INC. | $22.81 | 2021 | |
| Supernus Pharmaceuticals, INC. | $17.94 | 2023 | Qelbree |
| Vanda Pharmaceuticals INC. | $16.32 | 2025 | Hetlioz, Fanapt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Avent listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.